We are monitoring the impact of COVID-19 on APAC OTC Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 464
Share on
Share on

Asia Pacific Over the Counter Drugs Market Research Report - Segmented By Product Type, Formulation Type, Distribution Channels & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 464
Pages: 145

APAC OTC Drugs Market Size (2021 to 2026)

The Asia Pacific size over-the-counter drugs market was estimated at USD 56.73 Million in 2021. It is further projected to reach USD 91.41 Million by 2026 at a CAGR of 10.01% during the forecast period from 2021 to 2026.

Steadily increasing population in the region, particularly in countries like China, India, and Bangladesh, leading to high market penetration and boosting the growth of the over-the-counter (OTC) drugs market in the Asia Pacific. In addition, advancements in distribution channels led to increased accessibility of OTC drugs in the region, which is another major factor fuelling up the growth of the over-the-counter drugs market in the Asia Pacific. Furthermore, key market players in this region are another major factor supporting the growth rate of the over-the-counter drugs market in this area.

Using traditional home remedies in countries like India and others, owing to available knowledge on the internet, is limiting the growth of the Asia Pacific over-the-counter drugs market. In addition, the lack of awareness regarding effective drugs in rural areas is also restraining the development of the local market.

The rise in research and development activities from the private and public organizations for developing drug delivery systems, efficacious drugs that can be accessible at the nearest drug stores, medical shops, and online shopping is likely to expand growth opportunities over-the-counter drugs market over the forecast period. Furthermore, increasing healthcare expenditure and boosting economies of countries like China, India, Japan, and others due to continually growing population and rising disposable income are expected to create lucrative opportunities for the players in the Asia Pacific OTC drugs market during the forecast period. In addition, an increasing number of pharmaceutical companies, drug stores, supermarkets, retail outlets, hospital pharmacies, and e-commerce offers several opportunities to grow the over-the-counter drugs market in the Asia Pacific.

This research report on the Asia Pacific OTC Drugs Market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Analgesics
  • Cough, Cold, and Flu Products
  • Vitamins and Minerals
  • Dermatological Products
  • Gastrointestinal Products
  • Ophthalmic Products
  • Sleep Aid Products
  • Weight Loss/Diet Products
  • Others

By Formulation Type:

  • Tablets
  • Liquids
  • Ointments
  • Spray                             

By Distribution Channels: 

  • Pharmacies
  • Supermarkets/Hypermarkets
  • Convenience store
  • Others (online drug stores)                             

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Globally, the Asia Pacific market is one of the fastest-growing market regions in the over-the-counter drugs market. It is estimated to show a significant increase in the share during the forecast period. The regional market growth is expected to be fuelled by the rise in the population with the rise in the geriatric population, improving healthcare infrastructure. Also, the increase in infectious diseases with the rising prevalence of chronic diseases increases the inclination of pharmaceutical companies to switch from prescription drugs to OTC drugs is majorly driving the market growth in this region. The major growth contributors in the area are China, Japan, and India.

The Chinese OTC drugs market held the largest share of the APAC OTC drugs market in 2020, and it is likely to continue its growth during the forecast period. An increase in the sedentary lifestyle, poor eating habits, obesity, overweight is leading to a rise in the demand for OTC drugs which will eventually increase the growth of the market. Moreover, the presence of key market players in the market is leading the growth in the market. Also, due to the increase in the development and advancements in distribution channels, the demand for OTC drugs is rising; therefore, the sales of OTC drugs have accounted for 16.8 percent. Thus, these factors will drive the market for OTC drugs.

On the other hand, the Indian over-the-counter drugs market is projected to have significant growth due to an increase in the prevalence of chronic diseases. Consumers are more towards adopting self-medication as fatigue; anxiety is the most common disease for self-medication. In addition, with the increase in the disposable income in the region and the rise in the initiatives and investments from government and non-government firms for research purposes such as developing drug delivery systems with the increase in the medical and healthcare infrastructure, the growth is increasing of the market.

The Japanese over the drugs market is forecasted to saturate soon due to economic stagnation. On the other hand, the increasing adoption of western lifestyles and growing prosperities leads to increased market size and OTC demand.


A few of the notable companies operating in the APAC over the Counter Drugs Market profiled in the report are GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi, and Takeda.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Analgesics

                                5.1.2 Cough, Cold and Flu Products         

                                5.1.3 Vitamins and Minerals       

                                5.1.4 Dermatological Products   

                                5.1.5 Gastrointestinal Products 

                                5.1.6 Ophthalmic Products          

                                5.1.7 Sleep Aid Products              

                                5.1.8 Weight Loss/Diet Products               

                                5.1.9 Others      

                5.2 By Formulation Type                              

                                5.2.1 Tablets      

                                5.2.2 Liquids      

                                5.2.3 Ointments               

                                5.2.4 Sprays       

                5.3 Distribution Channels                             

                                5.3.1 Pharmacies             

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drug Stores)            

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 GlaxoSmithKline                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Johnson and Johnson                            

                8.3 Novartis                       

                8.4 Bayer                            

                8.5 Pfizer                            

                8.6 Boehringer Ingelheim                            

                8.7 Sanofi                           

                8.8 Takeda                         

                8.9 PGT Healthcare                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Over the Counter (OTC) Drugs Market, By Region, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Analgesics Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Cough Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Cold and Flu Products Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific Dermatological Products Market, By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Gastrointestinal Products Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Vitamins Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Minerals Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Weight Loss Products Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Sleep Aids Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Ophthalmic Products Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Smoking Cession Aids Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Other Products Market, By Region, From 2021 to 2026 (USD Million)
  15. China Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  16. India Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  17. Japan Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  18. South Korea Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  19. Australia Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample